General Archive
-
News releasesMultimillion-pound partnership breaks down barriers in MND research
Motor neuron disease (MND) is one of the most complex challenges in medical research. While excellent work is taking place…
-
News releasesCould an existing antibiotic be used to treat rare liver disease?
A new international clinical trial funded by medical research organisation LifeArc will test whether oral vancomycin, an existing antibiotic, could…
-
News releasesCelebrating 2 years of the network driving innovation for people with CF
This month marks 2 years of the Translational Innovation Hub Network for Cystic Fibrosis Lung Health and Infection, the CF…
-
News releasesNew £6m fellowship programme to help rare disease discoveries reach patients faster
We have partnered with the Academy of Medical Sciences, the UK’s national academy for medical science, to launch a new…
-
News releasesNew study brings hope for children with rare life-threatening kidney disease
We’re proud to have funded new research with Great Ormond Street Hospital Charity (GOSH Charity) and Kidney Research UK that…
-
News releasesIntroducing Raremap: a new way to navigate the rare disease landscape
LifeArc has collaborated with Rare Disease Research UK to launch Raremap, the UK’s first directory of rare disease organisations. There’s a vibrant…
-
News releasesLifeArc-founded RQ Bio secures £85.5 million to advance long-acting antibody for influenza prevention
The LifeArc-founded and backed biotech company RQ Bio has this week announced the completion of an oversubscribed $115 million (£85.5…
-
News releasesNew boost for personalised rare disease treatments as the Rare Therapies Launch Pad becomes part of LifeArc
We will be integrating the Rare Therapies Launch Pad (RTLP) into our organisation, marking an important next step in efforts…
-
News releasesWorld-first gene therapy to target devastating rare immune disorder
A first-of-its-kind gene therapy to treat people with CTLA-4 insufficiency, a rare and life-limiting inherited immune disorder, is being advanced…
-
News releasesLifeArc announces partnership with Elpida Therapeutics to accelerate gene therapies for ultra-rare diseases in children
We have announced a new partnership with Elpida Therapeutics to support the development of three gene therapy programmes targeting ultra-rare…
-
News releasesFirst projects backed by C-Further consortium to develop better treatments for children with cancer
Children and young people diagnosed with aggressive cancers could benefit from potential new treatments from two pioneering projects led by…
-
News releasesFirst‑of‑its‑kind UK data initiative to boost early diagnosis and deliver better treatments for children with rare diseases
We are joining forces with Great Ormond Street Hospital (GOSH) on a data initiative – KidsRare – with the aim…